FREE Case Evaluation: 1-888-887-3117
What is the CPAP lawsuit is a question millions of sleep apnea patients have been asking since Philips Respironics recalled millions of devices in 2021. Here's the essential information:
The CPAP Lawsuit Quick Facts:
The lawsuit centers on polyester-based polyurethane (PE-PUR) foam used in Philips devices for sound dampening. This foam can break down, releasing toxic particles and chemicals that users may inhale. Internal documents suggest Philips knew about foam degradation issues as early as 2015 but did not issue a recall until June 2021. By then, the FDA had received over 116,000 medical device reports related to the machines, including 561 reports of death.
The litigation has resulted in two major settlements: one covering economic losses for device purchases and another addressing personal injuries like cancer and respiratory diseases.
I'm Tim Burd, founder of Justice Hero. My experience in mass tort litigation has shown me the importance of clear information when people face complex legal situations. Understanding what is the CPAP lawsuit is the first step for affected individuals to make informed decisions about their rights and compensation.
At its core, what is the CPAP lawsuit about is the allegation that Philips Respironics knowingly sold defective CPAP, BiPAP, and ventilator machines. The lawsuit claims a fundamental design flaw turned these life-saving medical devices into potential health hazards by releasing toxic particles and chemicals into users' airways.
The central problem is the sound abatement foam used to make the devices quieter. This foam could break down over time, releasing black particles and dangerous chemicals that users would then inhale and ingest.
The lawsuits allege negligence, claiming Philips knew of these serious risks for years but failed to warn doctors or patients. The 2021 recall came long after the problems were reportedly finded, leaving millions unknowingly exposed to potential harm. For more on specific cancer risks, see our guide on CPAP cancer.
The defective component is the polyester-based polyurethane (PE-PUR) foam Philips used for noise and vibration reduction. When exposed to the heat and humidity common during sleep therapy, this PE-PUR foam could degrade and crumble.
This foam degradation led to visible black particles in the device tubing. More dangerously, microscopic particles and toxic chemicals were released through off-gassing, contaminating the user's air supply. The released carcinogenic chemicals include Toluene Diamine and Diethylene glycol, both serious health hazards. The lawsuits argue that Philips' failure to disclose these dangers constitutes a failure to warn patients and doctors.
A damning aspect of the lawsuit is the allegation that Philips knew about the foam degradation for years before taking action. Lawsuits claim that internal complaints and test results showed foam degradation issues as early as 2015, six years before the company issued its recall in June 2021. During those years, millions of people continued using their machines, unaware of the potential dangers.
This delayed action is compounded by allegations of misleading statements. While Philips allegedly knew about the foam problems, the company continued marketing the devices as safe and effective. FDA investigation findings have supported many of these claims, revealing a pattern of corporate knowledge without appropriate consumer warnings. As investigative reporting has shown, the FDA said Philips knew of problems for years before the public was informed.
This alleged cover-up shifts the focus of the lawsuit from a defective product to a breach of corporate responsibility and the duty to protect patients.
The Philips CPAP recall was one of the largest medical device recalls in history, affecting millions of devices globally. The FDA received over 116,000 Medical Device Reports (MDRs), including 561 reports of death, leading to a Class I recall classification—the most serious level, indicating a risk of severe health problems or death. Understanding what is the CPAP lawsuit involves knowing which devices and health risks are involved.
The June 2021 recall covered a wide range of Philips sleep and respiratory care devices manufactured between 2008 and 2021. The recall impacted many popular product lines, including a significant number of DreamStation (First Generation) CPAP, BiPAP, and ASV models. Other affected devices include the SystemOne and C-Series lines, specialized equipment like the OmniLab Advanced+ and Trilogy Ventilators (100 and 200), and certain A-Series BiPAP and Dorma models.
To be sure if your device is affected, visit the official Philips recall page and enter your device's serial number: Check your device on the Philips recall page.
The breakdown of the PE-PUR foam has been linked to an alarming range of health risks and injuries, which form the basis of the personal injury claims. The health issues reported by users span from irritating symptoms to severe, long-term conditions.
Respiratory Issues: Users have reported new or worsening conditions like asthma, Chronic Obstructive Pulmonary Disease (COPD), pneumonitis (lung inflammation), and pulmonary fibrosis—a severe lung-scarring disease. You can learn more about this condition from the Pulmonary Fibrosis Foundation. Other reported problems include general lung damage, shortness of breath, sinus infections, and persistent coughs.
Organ Damage: Allegations include damage to vital organs, with users reporting kidney disease or kidney cancer, and liver disease or liver cancer.
Cancers: The most serious allegations link foam exposure to various cancers, including: lung, nasal, throat, bladder, brain, breast, leukemia, lymphatic, multiple myeloma, prostate, rectal, stomach, testicular, and thyroid cancer.
Other Symptoms: Users have also reported frequent headaches, dizziness, airway irritation, chest pressure, nausea, vomiting, and general hypersensitivity reactions.
After a complex legal journey, major settlement agreements now offer compensation for those affected by the Philips CPAP recall. When asking what is the CPAP lawsuit today, the answer largely involves these settlements, which address economic loss claims (device costs), personal injury claims (health issues), and a medical monitoring fund. The cases have been consolidated into a Multidistrict Litigation (MDL) in the Western District of Pennsylvania to streamline the process.
On April 29, 2024, Philips agreed to a $1.1 billion settlement to resolve the personal injury lawsuits, a figure that reflects the scale of the alleged harm.
This $1.1 billion settlement is allocated for health-related claims:
This $1.1 billion is separate from an earlier settlement for economic losses, which totals over $613.3 million (initially $479 million). The economic loss settlement reimburses users for the cost of their devices. Together, these settlements address both the health and financial impacts of the recall.
It's important to understand the two main types of settlements, which address different kinds of harm under separate legal frameworks.
Economic Loss Settlement: This settlement is for those who purchased, leased, or rented a recalled Philips device. The fund, totaling over $613.3 million, reimburses the device cost. Compensation options included a Device Payment Award, a $100 Device Return Award (for devices returned by August 9, 2024), and a Device Replacement Award. The settlement received final court approval on April 25, 2024, with some payments beginning in late June 2024. For details, visit the Official economic loss settlement website.
Personal Injury Settlement: This settlement is for individuals who suffered physical harm or serious health issues from using the recalled devices. With $1.075 billion for personal injury claims and $25 million for medical monitoring, this settlement compensates for severe health problems like cancer and respiratory diseases. The funds cover medical bills, lost wages, and pain and suffering. Announced on April 29, 2024, this settlement awaits final court approval, with payments expected in 2025. Importantly, you can participate in both the economic loss and personal injury settlements if you qualify, as they cover different types of damages.
Understanding key deadlines and next steps is crucial for anyone wondering what the CPAP lawsuit means for them. Missing a deadline can mean losing your right to compensation. While some dates have passed, you can still take important actions to protect your health and legal rights.
The August 9, 2024 deadline for the economic loss settlement has passed. This date was critical for returning devices for a $100 award and for submitting certain claims without extra paperwork.
If you missed this deadline, the personal injury settlement of $1.1 billion is still awaiting final court approval, with payments expected to begin in 2025. This settlement addresses more serious health consequences.
There is also a December 10, 2024 registration deadline for a specific confidential settlement program for CPAP cancer cases, which is separate from the broader personal injury settlement.
The timeline for personal injury claims is still developing, so there is still time to take action if you've experienced health problems from your recalled device.
Taking the right steps now can protect both your health and your legal rights. Here is what we recommend:
You can pursue a personal injury claim even if you participate in the economic loss settlement. Do not wait to act, as the personal injury settlement process is ongoing.
The Philips CPAP recall has been a wake-up call for medical device safety, highlighting the critical role of the U.S. Food and Drug Administration (FDA). The implications of what is the CPAP lawsuit extend beyond the settlements, affecting users' health and Philips' future.
The FDA acts as a public health guardian during recalls, monitoring safety, mandating actions, and ensuring manufacturer compliance. Here’s how the FDA has been involved:
The FDA's actions demonstrate its commitment to corporate accountability and public safety.
The recall and lawsuits have profound, long-term consequences for both users and Philips.
For users, the consequences are deeply personal:
For Philips, the consequences are also profound:
The Philips CPAP lawsuit is a stark reminder of the importance of product safety, corporate responsibility, and regulatory oversight in the medical device industry.
So, what is the CPAP lawsuit? It's the culmination of a massive legal battle following the recall of millions of Philips CPAP, BiPAP, and ventilator machines. The recall was due to sound-dampening foam that could break down, releasing toxic particles and chemicals, leading to serious health concerns like cancer and respiratory illnesses, and leaving consumers with defective devices.
The good news is that this legal saga has resulted in major settlements. Philips has agreed to pay over $1.1 billion for personal injury and medical monitoring claims and a separate settlement of over $613.3 million to reimburse consumers for their defective devices. These agreements represent a significant victory for consumers and a step toward corporate accountability.
At Justice Hero, our mission is to simplify complex legal topics, like the Philips CPAP lawsuit, into clear, easy-to-understand information. We want to empower you to seek justice against corporate wrongdoing, and these settlements demonstrate that patient safety and corporate accountability can prevail.
If you or a loved one used a recalled Philips CPAP device and suffered harm, staying informed and exploring your legal options is vital. For comprehensive information and guidance on the CPAP Lawsuit, including eligibility criteria, important deadlines, and how to pursue a claim, please visit Find comprehensive information and guidance on the CPAP Lawsuit. We're here to help guide you through this process.
